Chronic Obstructive Pulmonary Disease (COPD)
The Spitalul de Pneumologie Dr. Lavinia Davidescu S.R.L conducts focused research on COPD, aiming to test new inhaled therapies, assess long‑term safety, and reduce the frequency of moderate‑to‑severe exacerbations that limit patients’ daily lives.
- Inhaled corticosteroid/long‑acting bronchodilator combination studies
- Evaluation of novel anti‑inflammatory agents
- Long‑term safety monitoring in chronic disease
- Strategies to lower exacerbation rates
- Comparative effectiveness of triple therapy regimens
With 12 clinical trials completed, the site contributes valuable data on improving lung function and quality of life for COPD patients across Europe.
Asthma (Mild to Moderate and Severe Uncontrolled)
Research at the Oradea center explores both routine and advanced treatments for asthma, from optimizing standard inhaler combinations to evaluating biologic adjuncts for severe uncontrolled disease, with the goal of enhancing airway control and preventing attacks.
- Step‑up therapy for mild‑to‑moderate asthma
- Biologic therapies as adjuncts in severe uncontrolled asthma
- Therapeutic equivalence of new inhaler devices
- Real‑world effectiveness of combination inhalers
- Pediatric and adolescent asthma management studies
The trials aim to improve forced expiratory volume outcomes and reduce reliance on rescue medication, offering new options for patients of all ages.
Idiopathic Pulmonary Fibrosis (IPF)
The facility’s IPF program evaluates promising anti‑fibrotic compounds, focusing on safety, tolerability, and the potential to slow disease progression while preserving lung capacity in a condition with few effective treatments.
- Development of novel anti‑fibrotic agents
- Long‑term safety assessments in progressive lung disease
- Biomarker analysis for disease activity
- Combination therapy strategies
- Quality‑of‑life outcome measurements
By generating robust clinical data, the site supports advances that could extend survival and improve daily functioning for individuals with idiopathic pulmonary fibrosis.
Respiratory Tract Disease Research
Across its portfolio, Spitalul de Pneumologie Dr. Lavinia Davidescu S.R.L addresses a range of chronic respiratory conditions, integrating patient‑focused endpoints with cutting‑edge therapeutic evaluation to enhance overall respiratory health.
- Integrated management of chronic respiratory diseases
- Multicenter collaboration throughout Europe
- Patient‑reported outcome measures
- Advanced pulmonary function testing
- Translational research linking biomarkers to treatment response
The site’s 12 trials, led by a dedicated investigator, contribute essential evidence for the development of safer and more effective treatments for respiratory tract diseases.
